Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Gazitt, Y' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gazitt, Y
      Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Gazitt, Y; Shaughnessy, P; Liu, Q
      Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Gazitt, Y; Shaughnessy, P; Devore, P
      Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Gazitt, Y; Shaughnessy, P; Liu, Q
      Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors

      STEM CELLS
    5. Gazitt, Y; Liu, Q
      Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients

      STEM CELLS
    6. Kim, K; Takimoto, R; Dicker, DT; Chen, YH; Gazitt, Y; El-Deiry, WS
      Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Liu, Q; El-Deiry, WS; Gazitt, Y
      Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines

      EXPERIMENTAL HEMATOLOGY
    8. Gazitt, Y; Reddy, SV; Alcantara, O; Yang, J; Boldt, DH
      A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate

      JOURNAL OF CELLULAR PHYSIOLOGY
    9. Anderson, JE; Tefferi, A; Craig, F; Holmberg, L; Chauncey, T; Appelbaum, FR; Guardiola, P; Callander, N; Freytes, C; Gazitt, Y; Razvillas, B; Deeg, HJ
      Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis

      BLOOD
    10. Gazitt, Y; Callander, N; Freytes, CO; Shaughnessy, P; Liu, Q; Tsai, TW; Devore, P
      Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    11. Gazitt, Y; Liu, Q
      High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34(+) PBSC in patients undergoing high-dose chemotherapy and stem cell rescue

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Gazitt, Y
      Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors

      STEM CELLS
    13. Liu, Q; Gazitt, Y
      Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes

      EXPERIMENTAL HEMATOLOGY
    14. Gazitt, Y; Freytes, CO; Callander, N; Tsai, TW; Alsina, M; Anderson, J; Holle, L; Cruz, J; Devoer, P; McGrath, M; West, G; Alvarez, R; Montgomery, W
      Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

      JOURNAL OF HEMATOTHERAPY
    15. Gazitt, Y; Shaughnessy, P; Montgomery, W
      Apoptosis-induced by trail and TNF-alpha in human multiple myeloma cells is not blocked by bcl-2

      CYTOKINE
    16. Gazitt, Y
      TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

      LEUKEMIA
    17. Menaa, C; Devlin, RD; Reddy, SV; Gazitt, Y; Choi, SJ; Roodman, GD
      Annexin II increases osteoclast formation by stimulating the proliferationof osteoclast precursors in human marrow cultures

      JOURNAL OF CLINICAL INVESTIGATION
    18. GAZITT Y; ROTHENBERG ML; HILSENBECK SG; FEY V; THOMAS C; MONTEGOMREY W
      BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS

      International journal of oncology
    19. GAZITT Y; FEY V; THOMAS C; ALVAREZ R
      BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO DEXAMETHASONE, BUT NOT MELPHALAN, IN MULTIPLE-MYELOMA CELLS

      International journal of oncology
    20. GAZITT Y; HU WX
      FAS (APO-1 CD95)-MEDIATED APOPTOSIS IS INDEPENDENT OF BCL-2 - A STUDYWITH CELL-LINES OVEREXPRESSING BCL-2 AND WITH BCL-2 TRANSFECTED CELL LIMES/

      International journal of oncology
    21. TRICOT G; GAZITT Y; LEEMHUIS T; JAGANNATH S; DESIKAN KR; SIEGEL D; FASSAS A; TINDLE S; NELSON J; JUTTNER C; TSUKAMOTO A; HALLAGAN J; ATKINSON K; READING C; HOFFMAN R; BARLOGIE B
      COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA

      Blood
    22. GAZITT Y; HILSENBECK SG
      PITFALLS IN THE RNA-BASED PCR AMPLIFICATION OF THE CDRIII SEQUENCE FOR QUANTITATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE-MYELOMA (COMMENTARY)

      Oncology Reports
    23. JETHMALANI SM; HENLE KJ; GAZITT Y; WALKER PD; WANG SY
      INTRACELLULAR-DISTRIBUTION OF HEAT-INDUCED STRESS GLYCOPROTEINS

      Journal of cellular biochemistry
    24. GAZITT Y; REDDY SV; TSAI T; ALCANTARA O; YANG J; BOLDT DH
      IRON DEPRIVATION BLOCKS BOTH CELL CYCLING AND DIFFERENTIATION AND INDUCES APOPTOSIS IN HL60 LEUKEMIA-CELLS INDUCED TO DIFFERENTIATE WITH PHORBOL-MYRISTATE ACETATE (PMA)

      Blood
    25. GAZITT Y; ROTHENBERG M; FEY V; MONTGOMERY W; ALVAREZ R
      GEMCITABINE (GEM) IS A PANCYTOTOXIC DRUG FOR VARIOUS MULTIPLE-MYELOMA(MM) CELL-LINES, WHEREAS TAXOL (TAX) CYTOTOXICITY IS DEPENDENT ON THEEXPRESSION OF BCL-2

      Blood
    26. GAZITT Y; READING CL
      AUTOLOGOUS TRANSPLANTATION WITH TUMOR-FREE GRAFT - A MODEL FOR MULTIPLE-MYELOMA PATIENTS

      Leukemia & lymphoma
    27. GAZITT Y
      THE ARKANSAS-CANCER-RESEARCH-CENTER, LITTLE-ROCK, AR, USA

      Oncology Reports
    28. HU WX; GAZITT Y
      BCL-2 PLAYS A MAJOR ROLE IN RESISTANCE TO DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES

      International journal of oncology
    29. TIAN EM; HU WX; GAZITT Y
      BCL-2 PLAYS A CRITICAL ROLE IN GROWTH AND IN SPONTANEOUS OR INDUCED APOPTOSIS IN MYELOMA CELL-LINES - A STUDY WITH INDUCIBLE BCL-2 TRANSFECTION CONSTRUCTS

      International journal of oncology
    30. TIAN EM; GAZITT Y
      THE ROLE OF P53, BCL-2 AND BAX NETWORK IN DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES

      International journal of oncology
    31. JAGANNATH TG; HAGANNATH S; BARLOGIE B; HOFFMAN R; READING C; ATKINSON K; GAZITT Y
      AUTOLOGOUS TRANSPLANTATION OF MULTIPLE-MYELOMA PATIENTS WITH FLOW-SORTED CD34-STEM CELLS PROVIDES VIRTUALLY TUMOR-FREE GRAFTS(THY+LIN)

      Blood
    32. GAZITT Y; TIAN EM; BARLOGIE B; READING CL; VESOLE DH; JAGANNATH S; SCHNELL J; HOFFMAN R; TRICOT G
      DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA AFTER TREATMENT WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

      Blood
    33. GAZITT Y; TIAN E; BARLOGIE B; GROVE C; READING CC; VESOLE DH; JAGANNATH S; SCHNELL J; HOFFMAN R; TRICOT G
      DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA PATIENTS FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE AND GM-CSF

      Experimental hematology
    34. GAZITT Y; LEE JH; TIAN E; GROVE C; BARLOGIE B; TRICOT G
      BCL-2 AND NOT BAX PROTEINS IS THE RATE-LIMITING STEP IN DEXAMETHASONE(DEX)-INDUCED APOPTOSIS IN MYELOMA

      Experimental hematology
    35. TIAN E; LEE JH; TRICOT G; BARLOGIE B; GAZITT Y
      BCL-2 AND NOT BAX PROTEIN IS THE RATE-LIMITING STEP IN DEXAMETHASONE (DEX)-INDUCED APOPTOSIS IN MYELOMA CELLS

      Blood
    36. TRICOT G; GAZITT Y; JAGANNATH S; VESOLE D; READING C; JUTTNER C; HOFFMAN R; BARLOGIE B
      CD34- PERIPHERAL-BLOOD STEM-CELLS (PBSC) EFFECT TIMELY TRILINEAGE ENGRAFTMENT IN MULTIPLE-MYELOMA (MM)(THY+LIN)

      Blood
    37. JAZIEH AR; GAZITT Y
      VITAMIN-D STIMULATES CFU-GM COLONIES AND OSTEOCLAST FORMATION IN BONE-MARROW OF MULTIPLE-MYELOMA (MM) PATIENTS

      Blood
    38. TRICOT G; BARLOGIE B; JAGANNATH S; VESOLE D; NAUCKE S; TIAN E; GAZITT Y
      DOUBLE AUTOTRANSPLANTS CAN INDUCE MOLECULAR REMISSIONS (MCR) IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA (MM)

      Blood
    39. GAZITT Y; READING CC; HOFFMAN R; WICKREMA A; VESOLE DH; JAGANNATH S; CONDINO J; LEE B; BARLOGIE B; TRICOT G
      PURIFIED CD34(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS() LIN()

      Blood
    40. GAZITT Y; CANTOR A; KOZA S; GRAHAMPOLE J
      A SAFE PROCEDURE FOR TRANSPORTING BONE-MARROW FOR PURGING IN A CENTRAL LABORATORY

      Oncology Reports
    41. AVRAHAM H; ERDOS GW; GAZITT Y
      DIFFERENTIAL EXPRESSION AND SUBCELLULAR-LOCALIZATION OF PROTEIN-KINASE-C, ALPHA, GAMMA, DELTA, XI AND ZETA ISOFORMS IN AGF T-CELLS - MODIFICATION DURING PMA-INDUCED DIFFERENTIATION

      International journal of oncology
    42. GAZITT Y; ROSENBERGER M; GRIPPO JF; LUCAS DA; PRANKERD RJ
      AROMATIC RETINOID ACID-DERIVATIVES ARE POTENT INDUCERS OF DIFFERENTIATION OF NEUROBLASTOMA-CELLS - STRUCTURE-FUNCTION RELATIONSHIP AND THE INVOLVEMENT OF THE NUCLEAR RETINOIC ACID RECEPTORS

      International journal of oncology
    43. GAZITT Y; ERDOS GW
      FLUCTUATIONS AND NUCLEAR TRANSLOCATION OF P53, C-MYC, CDC-2 AND PCNA PROTEINS DURING GROWTH AND COMMITMENT TO DIFFERENTIATION OF AGF CELLS

      International journal of oncology
    44. GAZITT Y; READING C; STEFANOVA R; BARLOGIE B; VESOLE D; JAQANNATH S; CONDINO J; LEE B; WICKREMA A; TRICOT G
      MYELOMA CELLS CAN BE EFFECTIVELY DEPLETED FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTING CD34-) STEM-CELLS(, THY(1)+, LIN()

      Experimental hematology
    45. ACKERMAN Z; WANDS JR; GAZITT Y; BRECHOT C; KEW MC; SHOUVAL D
      ENHANCEMENT OF HBSAG DETECTION IN SERUM OF PATIENTS WITH CHRONIC LIVER-DISEASE FOLLOWING REMOVAL OF CIRCULATING IMMUNE-COMPLEXES

      Journal of hepatology
    46. GAZITT Y; ERDOS GW
      FLUCTUATIONS AND ULTRASTRUCTURAL-LOCALIZATION OF ONCOPROTEINS AND CELL-CYCLE REGULATORY PROTEINS DURING GROWTH AND APOPTOSIS OF SYNCHRONIZED AGF CELLS

      Cancer research
    47. GAZITT Y; LEE JH; TIAN E; SAWYER J; TRICOT G
      DELETION OF THE RB OR P53 GENES IN HUMAN MULTIPLE-MYELOMA CELL-LINES DOES NOT RESULT IN DECREASED PROTEIN EXPRESSION WITH UP-REGULATION OF IL-6 AND INCREASED GROWTH-RATE

      Blood
    48. GAZITT Y; READING C; LEE JH; BARLOGIE B; VESOLE D; JAGANNATH S; LEE B; WICKREMA A; TRICOT G
      EFFECTIVE DEPLETION OF MYELOMA CELLS FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTION FOR CD34-CELLS(THY+LIN STEM)

      Blood
    49. GAZITT Y; READING C; LEE JH; BARLOGIE B; VESOLE D; JAGANNATH S; SIMONETTI D; DIGIUSTO R; SCHNELL J; ROSEN NR; TRICOT G
      DIFFERENTIAL PERIPHERAL-BLOOD MOBILIZATION OF TUMOR AND NORMAL HEMATOPOIETIC PROGENITOR CELLS (HPC) IN MULTIPLE-MYELOMA (MM)

      Blood
    50. READING C; SASAKI D; LEEMHUIS T; TICHENOR E; CHEN B; TSAO M; GAZITT Y; TRICOT G; HOFFMAN R
      CLINICAL-SCALE PURIFICATION OF CD34-1+LIN-STEM CELLS FROM MOBILIZED PERIPHERAL-BLOOD BY HIGH-SPEED FLUORESCENCE-ACTIVATED CELL SORTING FOR USE AS AN AUTOGRAFT FOR MULTIPLE-MYELOMA PATIENTS(THY)

      Blood
    51. GAZITT Y; CANTOR A; HE YJ; KOZA S; COHEN RJ; GRAHAMPOLE J
      PROGNOSTIC FACTORS IN PURGED MARROW FROM PATIENTS WITH NEUROBLASTOMA RECEIVING MYELOABLATIVE TREATMENT - TUMOR-CELL NUMBER, N-MYC PROTEIN, N-MYC GENE AMPLIFICATION AND RATE OF HEMATOLOGIC RECOVERY

      International journal of oncology
    52. GAZITT Y; LAVIA MF; ERDOS GW
      REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS

      International journal of oncology
    53. GAZITT Y; HE YJ; SHULTS K; STELZER GT; COHEN RJ
      ISOLATION AND CHARACTERIZATION OF AN EARLY T-HELPER INDUCER CELL-LINEWITH A UNIQUE PATTERN OF SURFACE PHENOTYPE, CONSTITUTIVE CYTOKINE SECRETION AND MYC ONCOGENE EXPRESSION/

      Leukemia
    54. GAZITT Y; ERDOS GW; COHEN RJ
      ULTRASTRUCTURAL-LOCALIZATION AND FLUCTUATION IN THE LEVEL OF THE PROLIFERATING CELL NUCLEAR ANTIGEN AND MYC ONCOPROTEINS IN SYNCHRONIZED NEUROBLASTOMA-CELLS

      Cancer research
    55. TRICOT G; DAO D; GAZITT Y; EPSTEIN J; SAWYER J; HOOVER R; BARLOGIE B
      DELETION OF THE RETINOBLASTOMA GENE (RB-1) IN MULTIPLE-MYELOMA (MM)

      Blood
    56. GAZITT Y; ERDOS GW
      REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 11:40:58